MarketWatchNeodvisenSredinaDejstva 75Objektivnost 90pred 20 dnevi Zdi se kot medicinski čudež: Kako je en kupon s QR kodo zmanjšal moj recept Walgreens za 618 dolarjev na 15 dolarjev?Članek opisuje osebno izkušnjo, ko je stranka Walgreensa znatno zmanjšala stroške recepta z uporabo kupona QR kode, ki je znižal ceno s 618 dolarjev na 15 dolarjev.
Ocena pristranskosti (Sredina): Članek se osredotoča na osebno anekdoto glede stroškov receptov in cen farmacevtskih izdelkov, kar je politično nabito vprašanje.
Zakaj dejstva (75): The article makes a specific claim about a QR code coupon reducing a prescription cost from $618 to $15 at Walgreens. While this is presented as an anecdotal experience, there is no explicit contradiction from other sources, so it can be considered plausible within the cross-source consensus. Howeve
Zakaj objektivnost (90): The article uses a quote from the author ('It feels like a medical miracle') which introduces a subjective reaction but does not overtly favor one perspective over another. The tone remains largely descriptive and personal rather than biased or opinionated.
MarketWatchNeodvisenProgresivnoDejstva 75Objektivnost 60pred 20 dnevi Zdravila ne bi smela biti dražja od hipoteke.V članku se trdi, da je sedanji sistem za določanje cen zdravil na recept pomanjkljiv, ker farmacevtska podjetja določajo cene na podlagi lastnih ocen vrednosti zdravila, ne pa na podlagi zunanjih dejavnikov, kot so dostopnost ali potrebe bolnikov.
Ocena pristranskosti (Progresivno): Članek kritizira sedanji model oblikovanja cen farmacevtskih izdelkov, ki je po naravi pristranski do korporativnih interesov, kar pomeni levičarsko kritiko tržnih rešitev.
Zakaj dejstva (75): The article discusses the pricing disparity between prescription drugs and mortgages, referencing broader systemic issues in pharmaceutical pricing. While no primary source document was available, the claims align with widely reported concerns from healthcare analysts and economists about the lack o
Zakaj objektivnost (60): The tone leans toward criticism of the pharmaceutical industry and suggests a biased perspective on the issue. Phrases like 'broken math' and 'solely determined by the companies creating the drugs' imply a judgmental stance rather than presenting neutral analysis. The article frames the problem as p